Bionano Genomics (BNGO) Shares Outstanding (2017 - 2026)

Bionano Genomics (BNGO) has 7 years of Shares Outstanding (Entity) data on file, last reported at $3.9 million in Q2 2025.

• For the quarter ending Q2 2025, Shares Outstanding (Entity) rose 231.35% year-over-year to $3.9 million; the trailing twelve-month figure through Jun 2025 stood at $3.9 million (up 231.35% YoY), and the FY2024 full-year result was $1.3 million, up 123.26% from the prior year.
• Shares Outstanding (Entity) grew to $3.9 million in Q2 2025, from $3.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $3.9 million in Q2 2025 to a low of $464750.0 in Q1 2021.
• A 5-year average of $997682.8 and a median of $532765.0 in 2023 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) soared 638.48% in 2021 and grew 2.62% in 2022, its largest moves.
• Tracing BNGO's Shares Outstanding (Entity) over 5 years: stood at $482767.0 in 2021, then increased by 2.62% to $495404.0 in 2022, then gained by 14.91% to $569280.0 in 2023, then jumped by 123.26% to $1.3 million in 2024, then surged by 207.58% to $3.9 million in 2025.
• Business Quant data shows BNGO's Shares Outstanding (Entity) at $3.9 million in Q2 2025, $3.1 million in Q1 2025, and $1.3 million in Q4 2024.